01:19 , Oct 6, 2018 |  BioCentury  |  Finance

In sight of uncharted territory

Strong growth from small- and mid-caps coupled with a late run from large cap biotechs has pushed the sector within sight of its all-time high in 2015. Some buysiders now are seeing red flags of...
07:00 , Aug 31, 2009 |  BC Week In Review  |  Company News

Warner Chilcott, P&G deal

Warner Chilcott acquired the global pharmaceuticals business of Procter & Gamble for $3.1 billion in cash. The deal includes P&G's marketed drugs Asacol HD mesalamine tablets to treat ulcerative colitis (UC); Actonel risedronate for osteoporosis;...
07:00 , Aug 10, 2009 |  BC Week In Review  |  Financial News

Onyx completes follow-on

Onyx Pharmaceuticals Inc. (NASDAQ:ONXX), Emeryville, Calif.   Business: Cancer   Date completed: 8/6/2009   Type: Follow-on   Raised: $122 million   Shares: 4 million   Price: $30.50   Shares after offering: 61.1 million   Underwriters:...
07:00 , Aug 10, 2009 |  BC Week In Review  |  Financial News

Onyx completes private placement of senior convertible notes

Onyx Pharmaceuticals Inc. (NASDAQ:ONXX), Emeryville, Calif.   Business: Cancer   Date completed: 8/6/2009   Type: Private placement of senior convertible notes   Raised: $200 million   Underwriters: Goldman Sachs; JPMorgan; Barclays Capital Inc.; Lazard  ...